×

What are you searching for?




Pharmaceuticals

4 Min read

GLENMARK PHARMA RECEIVES USFDA APPROVAL FOR FINGOLIMOD CAPSULES, 0.5 MG

Published On 19 Jun 2020 09:46 AM


SHARE THIS ARTICLE  


Highlights

• USFDA has given green signal for the production of Fingomolid Capsules that are used in treatment of relapsed form of multiple sclerosis in adults

• At present, Glenmark's portfolio comprises of 164 products authorized for distribution in the US market

• Shares of Glenmark Pharma saw intraday high of Rs 411.20 on the BSE

Glenmark Pharmaceuticals, world’s leading phar....


Tags : Glenmark Pharmaceuticals, Fingomolid Capsules, Gilenya Capsules, USFDA,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)